3D molecular generative framework for interaction-guided drug design

Abstract

Deep generative modeling has a strong potential to accelerate drug design. However, existing generative models often face challenges in generalization due to limited data, leading to less innovative designs with often unfavorable interactions for unseen target proteins. To address these issues, we propose an interaction-aware 3D molecular generative framework that enables interaction-guided drug design inside target binding pockets. By leveraging universal patterns of protein-ligand interactions as prior knowledge, our model can achieve high generalizability with limited experimental data. Its performance has been comprehensively assessed by analyzing generated ligands for unseen targets in terms of binding pose stability, affinity, geometric patterns, diversity, and novelty. Moreover, the effective design of potential mutant-selective inhibitors demonstrates the applicability of our approach to structure-based drug design.

Designing a molecule that favorably binds to a protein pocket is a keystone of drug discovery. Zhung et al. devise DeepICL, which leverages the generalizable features of non-covalent protein-ligand interactions on a 3D molecular generative model, improving the quality of AI-designed molecules.